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Background
Cell line generation (CLG) in the scope of bioproduc-
tion can be defined as a method to isolate a single cell
expressing a recombinant protein of interest. The stan-
dard method of CLG often involves the introduction of
the transgene into a cell in an attempt to use the cellu-
lar machinery for transcription, translation and secre-
tion. The use of random genomic integration via
auxotrophic selection markers creates different layers of
complexity, which leads to significant variations in
growth, productivity and stability among the subsequent
population [1]. The use of epigenetic modulators with
genetically improved cell lines have improved the “qual-
ity” of the resistant pools [2], while high throughput
technologies have simplified the clonal isolation process
[3]. However this “blackbox” approach still requires the
need to screen hundreds or thousands of individual cells
to find a line with the right quality attributes for manu-
facturing [4]. The challenge for CLG is to significantly
reduce the timeline of this process while ensuring
robustness and quality of the subsequent clones [5].
Materials and methods
The changing landscape of CLG has resulted in the
inclusion of robotics and high throughput technologies
such as flow cytometry into development pipelines. The
standard CLG method may include (but not limited to)
transfection, selection and stable pool generation fol-
lowed by a number of rounds of clonal enrichment
using the new technologies to isolate cells with the
necessary quality attributes for product manufacturing.
However we present a single step method to isolate
CHO cells for the expression of monoclonal antibodies
(mAb). The method employed here uses semi solid
cloning as well as the ClonePix FL (Molecular Devices)
to isolate mAb producing CHO cells. The method
examines directly seeding transfected cells into a semi-
solid matrix for selection, propagation and subsequent
isolation. By combining the selection with the isolation
in a single step, this direct approach allows for a more
efficient process in identifying a “serendipity event”, i.e.
a single cell that has been transfected with the vector
containing the gene of interest, undergone random inte-
gration/s at a non-essential locus and now has the abil-
ity to express the recombinant protein of interest.
Transfected cells were seeded into semi-solid matrix at
different seeding densities and then the positive colonies
were isolated using the ClonePix FL. The clones were
assessed for growth and productivity between the single
step and the standard methods.
Results
To assess the single step method, we examined the
growth, productivity and interclonal diversity from the
isolated clones. For colony formation in the semi solid
matrix, initial seeding density was increased from 500-
1000 cells/mL as recommended [2] to 40,000-80,000
cells/mL. Using the Clone Select Imager (Molecular
Devices), visible colonies were seen in the semi solid
matrix. An initial assessment via the FITC intensity of
the in situ fluorescence complex between the Clone
Detect (Molecular Devices) and the protein of interest
showed a higher signal from the single step method
when compared to the standard method. Both methods
showed that isolated clones were able to reach 10 million
cells/mL with specific productivity ranging from 10 to
50 pg/cell/day. It was clear the standard method provided
CHO clones with better growth characteristics while the
single step method allowed for the isolation of clones
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Conclusions
The single step method presents a simple change in
methodology for increasing the probability of isolating a
mAb expressing CHO line without changing the funda-
mental process. In fact, by directly seeding the trans-
fected cells into the semi solid matrix, the method
presents a more robust process eliminating the need for
bulk selection and a resistant pool, while also reducing
current timelines for CLG. With the rapid changes in
the biopharmaceutical industry, especially in biosimilar
developments [6], being able to establish a simple and
robust process for CLG can have a significant impact on
both novel and biosimilar pipelines.
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